Visual Impairment News and Research

Latest Visual Impairment News and Research

New UAB study shows connection between ADHD and vision problems in children

New UAB study shows connection between ADHD and vision problems in children

Apps that test visual function at home can identify vision problems long before traditional tests

Apps that test visual function at home can identify vision problems long before traditional tests

LouLou Foundation, Penn Med set up Program of Excellence to develop treatments for children with CDKL5

LouLou Foundation, Penn Med set up Program of Excellence to develop treatments for children with CDKL5

First patient enrolled in ThromboGenics' Phase II CIRCLE study of ocriplasmin in NPDR patients

First patient enrolled in ThromboGenics' Phase II CIRCLE study of ocriplasmin in NPDR patients

New studies provide insights into impact of vision loss among survivors of childhood cancers

New studies provide insights into impact of vision loss among survivors of childhood cancers

Study: Programmable electronic glasses help improve vision in children diagnosed with lazy eye

Study: Programmable electronic glasses help improve vision in children diagnosed with lazy eye

AAO announces launch of new online resource to improve eye care for children

AAO announces launch of new online resource to improve eye care for children

University of Leicester hosts sports event to raise awareness of Nystagmus

University of Leicester hosts sports event to raise awareness of Nystagmus

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

QUT's Professor Joanne Wood wins 'Nobel Prize' of international optometry

QUT's Professor Joanne Wood wins 'Nobel Prize' of international optometry

Up to 1 billion people could be at risk of going blind by 2050, say researchers

Up to 1 billion people could be at risk of going blind by 2050, say researchers

Alimera Sciences announces results from ongoing study on ILUVIEN

Alimera Sciences announces results from ongoing study on ILUVIEN

AMD Alliance hosts webinar to promote awareness and knowledge about macular disease

AMD Alliance hosts webinar to promote awareness and knowledge about macular disease

Gene therapy restores visual function in mouse model of LCA1

Gene therapy restores visual function in mouse model of LCA1

Researchers receive Bill & Melinda Gates Foundation grant to eliminate neglected tropical diseases

Researchers receive Bill & Melinda Gates Foundation grant to eliminate neglected tropical diseases

Retinal function, structure changes in proliferative diabetic retinopathy revealed

Retinal function, structure changes in proliferative diabetic retinopathy revealed

Brunel University student produces animated short film on understanding visually impaired people

Brunel University student produces animated short film on understanding visually impaired people

Benefit and harm of vision screening in preschool-aged children still unclear

Benefit and harm of vision screening in preschool-aged children still unclear

Bayer Yakuhin receives MHLW approval in Japan for EYLEA (aflibercept) Injection to treat RVO patients

Bayer Yakuhin receives MHLW approval in Japan for EYLEA (aflibercept) Injection to treat RVO patients

CHOP Global Health Center performs first rigorous study of CP outcomes in Africa

CHOP Global Health Center performs first rigorous study of CP outcomes in Africa

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.